Global Cancer Testing/Screening Market Size, Status and Forecast 2019-2025

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Cancer Testing/Screening Revenue
• 1.4 Market by Type
  • 1.4.1 Global Cancer Testing/Screening Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Lung Cancer
  • 1.4.3 Blood Cancer
  • 1.4.4 Bone Cancer
  • 1.4.5 Gall Bladder Cancer
  • 1.4.6 Others
• 1.5 Market by Application
  • 1.5.1 Global Cancer Testing/Screening Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospitals and Clinics
  • 1.5.3 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Cancer Testing/Screening Market Perspective (2015-2026)
• 2.2 Global Cancer Testing/Screening Growth Trends by Regions
  • 2.2.1 Cancer Testing/Screening Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Cancer Testing/Screening Historic Market Share by Regions (2015-2020)
  • 2.2.3 Cancer Testing/Screening Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Cancer Testing/Screening Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Cancer Testing/Screening Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Cancer Testing/Screening Players by Market Size
  • 3.1.1 Global Top Cancer Testing/Screening Players by Revenue (2015-2020)
  • 3.1.2 Global Cancer Testing/Screening Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Cancer Testing/Screening Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Cancer Testing/Screening Market Concentration Ratio
  • 3.2.1 Global Cancer Testing/Screening Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Cancer Testing/Screening Revenue in 2019
• 3.3 Cancer Testing/Screening Key Players Head office and Area Served
• 3.4 Key Players Cancer Testing/Screening Product Solution and Service
• 3.5 Date of Enter into Cancer Testing/Screening Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Cancer Testing/Screening Historic Market Size by Type (2015-2020)
• 4.2 Global Cancer Testing/Screening Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Cancer Testing/Screening Market Size by Application (2015-2020)
• 5.2 Global Cancer Testing/Screening Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Cancer Testing/Screening Market Size (2015-2020)
• 6.2 Cancer Testing/Screening Key Players in North America (2019-2020)
• 6.3 North America Cancer Testing/Screening Market Size by Type (2015-2020)
• 6.4 North America Cancer Testing/Screening Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Cancer Testing/Screening Market Size (2015-2020)
• 7.2 Cancer Testing/Screening Key Players in Europe (2019-2020)
• 7.3 Europe Cancer Testing/Screening Market Size by Type (2015-2020)
• 7.4 Europe Cancer Testing/Screening Market Size by Application (2015-2020)

8 China

• 8.1 China Cancer Testing/Screening Market Size (2015-2020)
• 8.2 Cancer Testing/Screening Key Players in China (2019-2020)
• 8.3 China Cancer Testing/Screening Market Size by Type (2015-2020)
• 8.4 China Cancer Testing/Screening Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Cancer Testing/Screening Market Size (2015-2020)
• 9.2 Cancer Testing/Screening Key Players in Japan (2019-2020)
• 9.3 Japan Cancer Testing/Screening Market Size by Type (2015-2020)
• 9.4 Japan Cancer Testing/Screening Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Cancer Testing/Screening Market Size (2015-2020)
• 10.2 Cancer Testing/Screening Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Cancer Testing/Screening Market Size by Type (2015-2020)
• 10.4 Southeast Asia Cancer Testing/Screening Market Size by Application (2015-2020)

11 India

• 11.1 India Cancer Testing/Screening Market Size (2015-2020)
• 11.2 Cancer Testing/Screening Key Players in India (2019-2020)
• 11.3 India Cancer Testing/Screening Market Size by Type (2015-2020)
• 11.4 India Cancer Testing/Screening Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Cancer Testing/Screening Market Size (2015-2020)
• 12.2 Cancer Testing/Screening Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Cancer Testing/Screening Market Size by Type (2015-2020)
• 12.4 Central & South America Cancer Testing/Screening Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Dias Orin
  • 13.1.1 Dias Orin Company Details
  • 13.1.2 Dias Orin Business Overview
  • 13.1.3 Dias Orin Cancer Testing/Screening Introduction
  • 13.1.4 Dias Orin Revenue in Cancer Testing/Screening Business (2015-2020))
  • 13.1.5 Dias Orin Recent Development
• 13.2 Epigenetics
  • 13.2.1 Epigenetics Company Details
  • 13.2.2 Epigenetics Business Overview
  • 13.2.3 Epigenetics Cancer Testing/Screening Introduction
  • 13.2.4 Epigenetics Revenue in Cancer Testing/Screening Business (2015-2020)
  • 13.2.5 Epigenetics Recent Development
• 13.3 Techlab
  • 13.3.1 Techlab Company Details
  • 13.3.2 Techlab Business Overview
  • 13.3.3 Techlab Cancer Testing/Screening Introduction
  • 13.3.4 Techlab Revenue in Cancer Testing/Screening Business (2015-2020)
  • 13.3.5 Techlab Recent Development
• 13.4 Positive Bioscience
  • 13.4.1 Positive Bioscience Company Details
  • 13.4.2 Positive Bioscience Business Overview
  • 13.4.3 Positive Bioscience Cancer Testing/Screening Introduction
  • 13.4.4 Positive Bioscience Revenue in Cancer Testing/Screening Business (2015-2020)
  • 13.4.5 Positive Bioscience Recent Development
• 13.5 Genextropy
  • 13.5.1 Genextropy Company Details
  • 13.5.2 Genextropy Business Overview
  • 13.5.3 Genextropy Cancer Testing/Screening Introduction
  • 13.5.4 Genextropy Revenue in Cancer Testing/Screening Business (2015-2020)
  • 13.5.5 Genextropy Recent Development
• 13.6 M Genomics
  • 13.6.1 M Genomics Company Details
  • 13.6.2 M Genomics Business Overview
  • 13.6.3 M Genomics Cancer Testing/Screening Introduction
  • 13.6.4 M Genomics Revenue in Cancer Testing/Screening Business (2015-2020)
  • 13.6.5 M Genomics Recent Development
• 13.7 20/20 GeneSystems
  • 13.7.1 20/20 GeneSystems Company Details
  • 13.7.2 20/20 GeneSystems Business Overview
  • 13.7.3 20/20 GeneSystems Cancer Testing/Screening Introduction
  • 13.7.4 20/20 GeneSystems Revenue in Cancer Testing/Screening Business (2015-2020)
  • 13.7.5 20/20 GeneSystems Recent Development
• 13.8 AB SCIEX
  • 13.8.1 AB SCIEX Company Details
  • 13.8.2 AB SCIEX Business Overview
  • 13.8.3 AB SCIEX Cancer Testing/Screening Introduction
  • 13.8.4 AB SCIEX Revenue in Cancer Testing/Screening Business (2015-2020)
  • 13.8.5 AB SCIEX Recent Development
• 13.9 Abbott Laboratories
  • 13.9.1 Abbott Laboratories Company Details
  • 13.9.2 Abbott Laboratories Business Overview
  • 13.9.3 Abbott Laboratories Cancer Testing/Screening Introduction
  • 13.9.4 Abbott Laboratories Revenue in Cancer Testing/Screening Business (2015-2020)
  • 13.9.5 Abbott Laboratories Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer